Beyond Data : Human Rights, Ethical and Social Impact Assessment in AI.
Main Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
The Hague :
T.M.C. Asser Press,
2022.
|
Edition: | 1st ed. |
Series: | Information Technology and Law Series
|
Subjects: | |
Online Access: | Click to View |
Table of Contents:
- Intro
- Foreword
- Preface
- Contents
- About the Author
- 1 Beyond Data
- Abstract
- 1.1 Introduction
- 1.2 Rise and Fall of Individual Sovereignty Over Data Use
- 1.3 Reconsidering Self-determination: Towards a Safe Environment
- 1.4 A Paradigm Shift: The Focus on Risk Assessment
- 1.5 HRESIA: A Multi-layered Process
- 1.6 The Role of Experts
- 1.7 Assessing the Impact of Data-Intensive AI Applications: HRESIA Versus PIA/DPIA, SIA and EtIA
- 1.8 The HRESIA and Collective Dimension of Data Use
- 1.9 Advantages of the Proposed Approach
- 1.10 Summary
- References
- 2 Human Rights Impact Assessment and AI
- Abstract
- 2.1 Introduction
- 2.2 A Legal Approach to AI-Related Risks
- 2.3 Human Rights Impact Assessment of AI in the HRESIA Model
- 2.3.1 Planning and Scoping
- 2.3.2 Data Collection and the Risk Analysis Methodology
- 2.4 The Implementation of the Model
- 2.4.1 A Case Study on Consumer Devices Equipped with AI
- 2.4.1.1 Planning and Scoping
- 2.4.1.2 Initial Risk Analysis and Assessment
- 2.4.1.3 Results of the Initial Assessment
- 2.4.1.4 Mitigation Measures and Re-assessment
- 2.4.2 A Large-Scale Case Study: Smart City Government
- 2.5 Summary
- References
- 3 The Social and Ethical Component in AI Systems Design and Management
- Abstract
- 3.1 Beyond Human Rights Impact Assessment
- 3.1.1 The Socio-ethical Framework: Uncertainty, Heterogeneity and Context Dependence
- 3.1.2 The Risk of a 'Transplant' of Ethical Values
- 3.1.3 Embedding Ethical and Societal Values
- 3.1.4 The Role of the Committee of Experts: Corporate Case Studies
- 3.2 Existing Models in Medical Ethics and Research Committees
- 3.2.1 Clinical Ethics Committees
- 3.2.2 Research Ethics Committees
- 3.2.3 Ethics Committees for Clinical Trials
- 3.2.4 Main Inputs in Addressing Ethical and Societal Issues in AI.
- 3.3 Ad Hoc HRESIA Committees: Role, Nature, and Composition
- 3.4 Rights-Holder Participation and Stakeholder Engagement
- 3.5 Summary
- References
- 4 Regulating AI
- Abstract
- 4.1 Regulating AI: Three Different Approaches to Regulation
- 4.2 The Principles-Based Approach
- 4.2.1 Key Principles from Personal Data Regulation
- 4.2.1.1 Primacy of the Human Being
- 4.2.1.2 Human Control and Oversight
- 4.2.1.3 Participation and Democratic Oversight on AI Development
- 4.2.1.4 Transparency and Intelligibility
- 4.2.1.5 Precautionary Approach and Risk Management
- 4.2.1.6 Accountability
- 4.2.1.7 Data Minimisation and Data Quality
- 4.2.1.8 Role of Experts and Participation
- 4.2.1.9 Algorithm Vigilance
- 4.2.2 Key Principles from Biomedicine Regulation
- 4.2.2.1 Primacy of the Human Being
- 4.2.2.2 Equitable Access to Health Care
- 4.2.2.3 Acceptability
- 4.2.2.4 Principle of Beneficence
- 4.2.2.5 Private Life and Right to Information
- 4.2.2.6 Professional Standards
- 4.2.2.7 Non-discrimination
- 4.2.2.8 Role of Experts
- 4.2.2.9 Public Debate
- 4.2.3 A Contribution to a Future Principles-Based Regulation of AI
- 4.3 From Design to Law - The European Approaches and the Regulatory Paradox
- 4.3.1 The Council of Europe's Risk-Based Approach Centred on Human Rights, Democracy and Rule of Law
- 4.3.2 The European Commission's Proposal (AIA) and Its Conformity-Oriented Approach
- 4.4 The HRESIA Model's Contribution to the Different Approaches
- 4.5 Summary
- References
- 5 Open Issues and Conclusions
- Abstract
- 5.1 Addressing the Challenges of AI
- 5.2 The Global Dimension of AI
- 5.3 Future Scenarios
- References
- Index.